Page last updated: 2024-12-08

hainanolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

hainanolide: from bark of Cephalotaxux hainensis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25092280
CHEMBL ID2448553
MeSH IDM0074825

Synonyms (3)

Synonym
hainanolide
CHEMBL2448553
(1s,11s,12r,13r,15r,16r,19s)-8,19-dimethyl-14,17-dioxahexacyclo[13.3.1.01,11.04,10.09,13.012,16]nonadeca-4,7,9-triene-6,18-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID1827423Antiproliferative activity against human A-375 cells assessed as reduction in cell viability after 24 hrs by MTT assay
AID331263Effect on drug-uptake in imatinib-induced human HT29 apoptotic cells2008Bioorganic & medicinal chemistry letters, Jun-15, Volume: 18, Issue:12
Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis.
AID1827427Binding affinity to RACK1 in human A-375 cells assessed as prevention of pronase-mediated protein degradation at 5 to 20 uM preincubated for 60 mins followed by enzyme addition and measured after 25 mins by immunoblotting based DARTS assay
AID1827434Inhibition of FAK in human A-375 cells assessed as reduction in Src activation at 0.5 to 4 uM measured after 24 hrs by Western blotting analysis
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1827431Inhibition of epithelial-mesenchymal transition in human A-375 cells assessed as downregulation of Snail expression at 0.5 to 4 uM measured after 24 hrs by Western blotting analysis
AID1827433Inhibition of FAK phosphorylation in human A-375 cells measured after 24 hrs by Western blotting analysis
AID1827430Inhibition of epithelial-mesenchymal transition in human A-375 cells assessed as downregulation of N-cadherin expression at 0.5 to 4 uM measured after 24 hrs by Western blotting analysis
AID1827435Inhibition of FAK in human A-375 cells assessed as reduction in STAT3 activation at 0.5 to 4 uM measured after 24 hrs by Western blotting analysis
AID1827432Inhibition of epithelial-mesenchymal transition in human A-375 cells assessed as upregulation of E-cadherin expression at 0.5 to 4 uM measured after 24 hrs by Western blotting analysis
AID1827428Inhibition of cell migration in human A-375 cells at measured after 24 hrs by phase contrast microscopy based wound healing assay
AID1827442Inhibition of RACK1-FAK protein-protein interaction in human A-375 cells measured after 24 hrs by co-immunoprecipitation assay
AID1827429Inhibition of cell invasion in human A-375 cells at measured after 24 hrs by crystal violet staining based imaging analysis
AID409959Inhibition of bovine liver MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1827422Binding affinity to RACK1 in human A-375 cells assessed as prevention of temperature dependent protein degradation at 10 uM preincubated for 60 mins at room temperature followed by heat treatment at 45 to 63 degree C for 5 mins measured by immunoblotting
AID331262Effect on drug-uptake in imatinib-induced human K562 apoptotic cells2008Bioorganic & medicinal chemistry letters, Jun-15, Volume: 18, Issue:12
Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis.
AID1827440Inhibition of STAT3 in human A-375 cells assessed as decrease in Bcl2 protein level at 0.5 to 4 uM measured after 24 hrs by western blot analysis
AID1827441Inhibition of STAT3 in human A-375 cells assessed as decrease in c-Myc protein level at 0.5 to 4 uM measured after 24 hrs by western blot analysis
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's2 (15.38)24.3611
2020's3 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]